Sinclair Research has named Scott E. Boley, PhD, DABT, as vice president of toxicology. In this newly created role, he will have overall responsibility for driving the growth of Sinclair’s toxicology efforts and fostering relationships with new and current customers.   Dr. Boley became a board-certified toxicologist in 2003, and has extensive expertise in drug development as well as the regulatory expectations for a variety of test article types and indications. He will be applying his breadth...